Concomitant inactivation of Rb and E2f8 in hematopoietic stem cells synergizes to induce severe anemia

Blood

Volumn 119, Issue 19, 2012, Pages 4532-4542

  Hu, Tinghui ^a   Ghazaryan, Seda ^a   Sy, Chandler ^a   Wiedmeyer, Charles ^b   Chang, Victor ^a,c   Wu, Lizhao ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CRE RECOMBINASE; ERYTHROPOIETIN; HEMOGLOBIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F8; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL LINEAGE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE COUNT; ERYTHROID CELL; ERYTHROPOIESIS; GENE INACTIVATION; HEMATOCRIT; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; RETICULOCYTE COUNT;

EID: 84861088394     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-388231     Document Type: Article

References (47)

1. Clarke AR, Maandag ER, van Roon M, et al. Requirement for a functional Rb-1 gene in murine development. Nature. 1992;359(6393):328-330.
2. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature. 1992;359(6393):295-300.
3. Lee EY, Chang CY, Hu N, et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature. 1992; 359(6393):288-294.
4. Macleod KF. The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system. Nat Rev Cancer. 2008; 8(10):769-781.
5. Walkley CR, Sankaran VG, Orkin SH. Rb and hematopoiesis: stem cells to anemia. Cell Div. 2008;3:13.
6. Clark AJ, Doyle KM, Humbert PO. Cell-intrinsic requirement for pRb in erythropoiesis. Blood. 2004;104(5):1324-1326. (Pubitemid 39166506)
7. Daria D, Filippi MD, Knudsen ES, et al. The retinoblastoma tumor suppressor is a critical intrinsic regulator for hematopoietic stem and progenitor cells under stress. Blood. 2008;111(4):1894-1902. (Pubitemid 351451498)
8. Iavarone A, King ER, Dai XM, Leone G, Stanley ER, Lasorella A. Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. Nature. 2004; 432(7020):1040-1045. (Pubitemid 40052236)
9. Spike BT, Dirlam A, Dibling BC, et al. The Rb tumor suppressor is required for stress erythropoiesis. EMBO J. 2004;23(21):4319-4329. (Pubitemid 39546169)
10. Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell. 2007;129(6):1081-1095. (Pubitemid 46908695)
11. Wu L, de Bruin A, Saavedra HI, et al. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature. 2003; 421(6926):942-947. (Pubitemid 36288025)
12. Sankaran VG, Orkin SH, Walkley CR. Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev. 2008;22(4):463-475. (Pubitemid 351272754)
13. Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene. 2005;24(17):2810-2826. (Pubitemid 40638092)
14. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol. 2002;3(1):11-20. (Pubitemid 135709914)
15. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998;12(15):2245-2262. (Pubitemid 28371346)
16. Nevins JR. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 1998;9(8):585-593. (Pubitemid 28367248)
17. van den Heuvel S, Dyson NJ. Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol. 2008;9(9):713-724.
18. Lammens T, Li J, Leone G, De Veylder L. Atypical E2Fs: new players in the E2F transcription factor family. Trends Cell Biol. 2009;19(3):111-118.
19. Trimarchi JM, Fairchild B, Wen J, Lees JA. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc Natl Acad Sci U S A. 2001;98(4):1519-1524. (Pubitemid 32165531)
20. Chong JL, Tsai SY, Sharma N, et al. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. Mol Cell Biol. 2009; 29(2):414-424.
21. Lee EY, Cam H, Ziebold U, Rayman JB, Lees JA, Dynlacht BD. E2F4 loss suppresses tumorigenesis in Rb mutant mice. Cancer Cell. 2002;2(6): 463-472. (Pubitemid 41043951)
22. Lee EY, Yuan TL, Danielian PS, West JC, Lees JA. E2F4 cooperates with pRB in the development of extra-embryonic tissues. Dev Biol. 2009;332(1):104-115.
23. Parisi T, Yuan TL, Faust AM, Caron AM, Bronson R, Lees JA. Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues. Mol Cell Biol. 2007; 27(6):2283-2293. (Pubitemid 46418482)
24. Saavedra HI, Wu L, de Bruin A, et al. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ. 2002;13(5):215-225. (Pubitemid 34651182)
25. Wenzel PL, Wu L, de Bruin A, et al. Rb is critical in a mammalian tissue stem cell population. Genes Dev. 2007;21(1):85-97. (Pubitemid 46089710)
26. Ziebold U, Lee EY, Bronson RT, Lees JA. E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas. Mol Cell Biol. 2003;23(18):6542-6552. (Pubitemid 37075765)
27. Ziebold U, Reza T, Caron A, Lees JA. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 2001;15(4):386-391. (Pubitemid 32186999)
28. Dirlam A, Spike BT, Macleod KF. Deregulated E2f-2 underlies cell cycle and maturation defects in retinoblastoma null erythroblasts. Mol Cell Biol. 2007;27(24):8713-8728.
29. Heinrich AC, Pelanda R, Klingmuller U. A mouse model for visualization and conditional mutations in the erythroid lineage. Blood. 2004;104(3):659-666. (Pubitemid 38970558)
30. Kühn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science. 1995; 269(5229):1427-1429.
31. Li J, Ran C, Li E, et al. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell. 2008;14(1): 62-75.
32. Vooijs M, te Riele H, van der Valk M, Berns A. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells. Oncogene. 2002;21(30):4635-4645. (Pubitemid 34833141)
33. Kalfa TA, Pushkaran S, Zhang X, et al. Rac1 and Rac2 GTPases are necessary for early erythropoietic expansion in the bone marrow but not in the spleen. Haematologica. 2010;95(1):27-35.
34. Spolarics Z, Condon MR, Siddiqi M, Machiedo GW, Deitch EA. Red blood cell dysfunction in septic glucose-6-phosphate dehydrogenase-deficient mice. Am J Physiol Heart Circ Physiol. 2004;286(6):H2118-2126. (Pubitemid 38685225)
35. Chen H, Khan AA, Liu F, et al. Combined deletion of mouse dematin-headpiece and beta-adducin exerts a novel effect on the spectrin-actin junctions leading to erythrocyte fragility and hemolytic anemia. J Biol Chem. 2007;282(6): 4124-4135. (Pubitemid 47084499)
36. Kalfa TA, Pushkaran S, Mohandas N, et al. Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton. Blood. 2006;108(12):3637-3645. (Pubitemid 44864539)
37. Liu J, Guo X, Mohandas N, Chasis JA, An X. Membrane remodeling during reticulocyte maturation. Blood. 2010;115(10):2021-2027.
38. McMullin MF. The molecular basis of disorders of the red cell membrane. J Clin Pathol. 1999;52(4): 245-248. (Pubitemid 29161483)
39. De Franceschi L, Rivera A, Fleming MD, et al. Evidence for a protective role of the Gardos channel against hemolysis in murine spherocytosis. Blood. 2005;106(4):1454-1459. (Pubitemid 41129615)
40. McMullin MF. The molecular basis of disorders of red cell enzymes. J Clin Pathol. 1999;52(4):241-244. (Pubitemid 29161482)
41. Peters LL, Jindel HK, Gwynn B, et al. Mild spherocytosis and altered red cell ion transport in protein 4.2-null mice. J Clin Invest. 1999;103(11): 1527-1537.
42. Rouyer-Fessard P, Leroy-Viard K, Domenget C, Mrad A, Beuzard Y. Mouse beta thalassemia, a model for the membrane defects of erythrocytes in the human disease. J Biol Chem. 1990; 265(33):20247-20251. (Pubitemid 120014002)
43. Kadri Z, Shimizu R, Ohneda O, et al. Direct binding of pRb/E2F-2 to GATA-1 regulates maturation and terminal cell division during erythropoiesis. PLoS Biol. 2009;7(6):e1000123.
44. Rekhtman N, Choe KS, Matushansky I, Murray S, Stopka T, Skoultchi AI. PU. 1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation. Mol Cell Biol. 2003;23(21): 7460-7474. (Pubitemid 37271448)
45. Tallack MR, Keys JR, Humbert PO, Perkins AC. EKLF/KLF1 controls cell cycle entry via direct regulation of E2f2. J Biol Chem. 2009;284(31): 20966-20974.
46. Nakano M, Ohneda K, Yamamoto-Mukai H, et al. Transgenic over-expression of GATA-1 mutant lacking N-finger domain causes hemolytic syndrome in mouse erythroid cells. Genes Cells. 2005;10(1):47-62. (Pubitemid 40352617)
47. Perkins AC, Peterson KR, Stamatoyannopoulos G, Witkowska HE, Orkin SH. Fetal expression of a human Agamma globin transgene rescues globin chain imbalance but not hemolysis in EKLF null mouse embryos. Blood. 2000;95(5):1827-1833. (Pubitemid 30120849)